# Sydney Tang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sydney-tang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,121 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 68 |
| i10-index | 251 |
| Last Known Institution | Chinese University of Hong Kong |
| OpenAlex ID | https://openalex.org/A5100735668 |
| ORCID iD | 0000-0002-6862-1941 |
| Works | 527 |

## Researcher papers

Showing 12 of 17.

- [KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/kdigo-2021-clinical-practice-guideline-for-the-management-of-glomerular-diseases/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Innate immunity in diabetic kidney disease](https://scholariq.org/papers/innate-immunity-in-diabetic-kidney-disease/)
- [IgA nephropathy](https://scholariq.org/papers/iga-nephropathy-2/)
- [Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/heart-failure-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese–Western Medicine for the Management of 2019 Novel Coronavirus Disease](https://scholariq.org/papers/covid-19-an-update-on-the-epidemiological-clinical-preventive-and-therapeutic/)
- [Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy](https://scholariq.org/papers/toll-like-receptor-4-promotes-tubular-inflammation-in-diabetic-nephropathy/)
- [Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo](https://scholariq.org/papers/albumin-stimulates-interleukin-8-expression-in-proximal-tubular-epithelial-cells/)
- [Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-1-conclusions-from-a-kidney/)
- [Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/blood-pressure-and-volume-management-in-dialysis-conclusions-from-a-kidney/)
- [Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial](https://scholariq.org/papers/sparsentan-in-patients-with-iga-nephropathy-a-prespecified-interim-analysis-from/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Chinese University of Hong Kong](https://scholariq.org/institutions/chinese-university-of-hong-kong/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.